News & Events

COVID-19 Clinical Trials

CDC illustration of coronavirus

MUSC researchers are involved in clinical trials studying the safety and efficacy of COVID-19 treatments and preventative strategies.

Innovative HR Tool

An MUSC team received national recognition for the Matrix, a tool that helps to ensure successful recruitment and retention of clinical research professionals.

Bettering the Odds

Illustration of a boxing glove coming out of a pill. Licensed from Illustration by Wildpixel.

When diagnosed with leukemia, MUSC Health Charleston CEO David Zaas benefited from a clinical trial. He wants all MUSC patients to have the same opportunity.

LOX's Role in Scleroderma

Dr. Carol Feghali Bostwick, professor in the Department of Medicine, and graduate student Xinh Xinh Nguyen.

MUSC researchers, including a SCTR TL1 trainee, show that lysyl oxidase, or LOX, promotes fibrosis in scleroderma and could be a biomarker of treatment response.


Upcoming Events

SCTR Lunch & Learns

View event details for monthly offerings on the SCTR Lunch & Learn page. 

SCTR Scientific Retreat

COVID-19: State of the Science
Keynote Speaker: Mark R. Denison, M.D., Vanderbilt University Medical Center
Friday, April 23, 2021 | 9:00 a.m. | Visit the webpage

SCTR Monthly Newsletter

Subscribe to SCTR eNews to receive our Weekly Bulletin and Monthly Newsletter.

Monthly Newsletter Archive